Literature DB >> 1892181

Use of hydroxyurea in chronic myeloid leukemia during pregnancy: a case report.

M Patel1, I A Dukes, J C Hull.   

Abstract

The concomitant occurrence of pregnancy and chronic myeloid leukemia is uncommon. The use of hydroxyurea in chronic myeloid leukemia during pregnancy is unknown. We report on a patient with chronic myeloid leukemia in whom hydroxyurea was used during pregnancy with a successful outcome for both mother and fetus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892181     DOI: 10.1016/0002-9378(91)90285-y

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

Review 1.  Pregnancies in patients with chronic myeloid leukemia in the era of imatinib.

Authors:  Liang-Piu Koh; Devendra Kanagalingam
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

2.  Cancer in pregnancy: maternal-fetal conflict.

Authors:  F S Oduncu; R Kimmig; H Hepp; B Emmerich
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-18       Impact factor: 4.553

Review 3.  How I treat newly diagnosed chronic phase CML.

Authors:  Jorge Cortes; Hagop Kantarjian
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

4.  Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy.

Authors:  Monika Conchon; Sabri S Sanabani; Mariana Serpa; Mafalda M Y Novaes; Luciana Nardinelli; Patrícia B Ferreira; Pedro Enrique Dorliac-Llacer; Israel Bendit
Journal:  Adv Hematol       Date:  2010-03-07

Review 5.  An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians.

Authors:  Austin Granatowicz; Caroline I Piatek; Elizabeth Moschiano; Ihab El-Hemaidi; Joel D Armitage; Mojtaba Akhtari
Journal:  Korean J Fam Med       Date:  2015-09-18

6.  Imatinib use in pregnancy.

Authors:  Michael J Webb; Debbie Jafta
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

7.  Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review.

Authors:  Domenico Santorsola; Elisabetta Abruzzese
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-02-15       Impact factor: 2.576

Review 8.  Hematologic malignancies during pregnancy: A review.

Authors:  Hossam K Mahmoud; Mohamed A Samra; Gamal M Fathy
Journal:  J Adv Res       Date:  2016-02-08       Impact factor: 10.479

9.  Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.

Authors:  Monika Conchon; Sabri S Sanabani; Israel Bendit; Fernanda Maria Santos; Mariana Serpa; Pedro Enrique Dorliac-Llacer
Journal:  J Hematol Oncol       Date:  2009-10-06       Impact factor: 17.388

Review 10.  Tyrosine kinase inhibitors and pregnancy.

Authors:  Elisabetta Abruzzese; Malgorzata Monika Trawinska; Alessio Pio Perrotti; Paolo De Fabritiis
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.